Zeria Pharmaceutical Co., Ltd.
4559.T
Get informed when a big investor buys or sells
+ FollowMarket Cap$84.85B
Close$
Share Statistics
| Market cap | $84.85 Billion |
|---|---|
| Enterprise Value | $93.62 Billion |
| Dividend Yield | $50.00 (2.60%) |
| Earnings per Share | $191.8 |
| Beta | 0.06 |
| Outstanding Shares | 44,079,398 |
Return
| Return on Equity | 7.62% |
|---|---|
| Return on Assets | 4.71% |
| Return on Invested Capital | 10.39% |
Valuation & Multiples
| P/E Ratio | 10.31 |
|---|---|
| PEG | -50.08 |
| Price to Sales | 0.93 |
| Price to Book Ratio | 0.78 |
| Enterprise Value to Revenue | 1.03 |
| Enterprise Value to EBIT | 7.31 |
| Enterprise Value to Net Income | 11 |
| Total Debt to Enterprise | 0.39 |
| Debt to Equity | 0.34 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 6, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$21.60 B
Average shareholder expectationNext Earnings Call
Expected Date
November 4, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$22.65 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Zeria Pharmaceutical Co., Ltd.
1,748 employees
CEO: Sachiaki Ibe Zeria Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures, sells, imports, and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural and industrial chemicals, and reagents in Ja...